Advertisement

Topics

"Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients" Drugs and Medication Database

06:00 EST 23rd February 2019 | BioPortfolio

Here are the most relevant "Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients" Drugs and Medications that we have found in our database.

More Information about "Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients" on BioPortfolio

We have published hundreds of Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients news stories on BioPortfolio along with dozens of Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients Clinical Trials and PubMed Articles about Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients Companies in our database. You can also find out about relevant Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients Drugs and Medications on this site too.

Showing "Monthly Follow Interferon Gamma Releasing Assay IGRA Among" Drugs and Medications 1–25 of 121

Probably Relevant

Alferon [hemispherx biopharma, inc]

NA

Ribasphere [kadmon pharmaceuticals, llc]

These highlights do not include all the information needed to use RIBASPHERE (ribavirin capsules USP) safely and effectively. See full prescribing information for RIBASPHERE.RIBASPHERE (ribavirin capsules USP) 200 mg, for oral useInitial U.S. Approval: 19

Possibly Relevant

Rebetol [merck sharp & dohme corp.]

These highlights do not include all the information needed to use REBETOL safely and effectively. See full prescribing information for REBETOL.REBETOL (ribavirin USP) capsules, for oral use REBETOL (ribavirin USP) oral solutionInitial U.S. Approval: 1998

Ribavirin [sandoz inc]

These highlights do not include all the information needed to use RIBAVIRIN CAPSULES safely and effectively. See full prescribing information for RIBAVIRIN CAPSULES.Ribavirin capsules, for oral useInitial U.S. Approval: 1998

Actimmune [horizon pharma inc.]

These highlights do not include all the information needed to use ACTIMMUNE safely and effectively. See full prescribing information for ACTIMMUNE. ACTIMMUNE (interferon gamma-1b) injection, for subcutaneous useInitial U.S. Approval: 1990

Ribavirin [cadila healthcare limited]

These highlights do not include all the information needed to use RIBAVIRIN CAPSULES safely and effectively. See full prescribing information for RIBAVIRIN CAPSULES. RIBAVIRIN capsules, for oral use Initial U.S. Approval: 1998

Ribavirin [zydus pharmaceuticals (usa) inc.]

These highlights do not include all the information needed to use RIBAVIRIN CAPSULES safely and effectively. See full prescribing information for RIBAVIRIN CAPSULES. RIBAVIRIN capsules, for oral useInitial U.S. Approval: 1998

Intron a [merck sharp & dohme corp.]

INTRON A Interferon alfa-2b, recombinant

Sylatron [merck sharp & dohme corp.]

These highlights do not include all the information needed to use SYLATRON safely and effectively. See full prescribing information for SYLATRON. SYLATRON™ (peginterferon alfa-2b) for injection, for subcutaneous use Initial U.S. Approval: 2011

Rebif [emd serono, inc.]

These highlights do not include all the information needed to use REBIF safely and effectively. See full prescribing information for REBIF. REBIF (interferon beta-1a), for subcutaneous injectionInitial U.S. Approval: 1996

Moderiba [abbvie inc.]

These highlights do not include all the information needed to use Moderiba (ribavirin, USP) safely and effectively. See full prescribing information for Moderiba (ribavirin, USP). Moderiba (ribavirin, USP) Tablets for oral useInitial U.S. Approval: 2002

Ribavirin [sandoz inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral useInitial U.S. Approval: 2002

Ribavirin [richmond pharmaceuticals, inc.]

These highlights do not include all the information needed to use ribavirin tablets safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets for oral useInitial U.S. Approval: 2002

Ribavirin [aurobindo pharma limited]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral use Initial U.S. Approval: 2002

Ribavirin [zydus pharmaceuticals (usa) inc.]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral useInitial U.S. Approval: 2002

Ribasphere ribapak [kadmon pharmaceuticals, llc]

These highlights do not include all the information needed to use RIBASPHERE® (ribavirin, USP) safely and effectively. See full prescribing information for RIBASPHERE® (ribavirin, USP). RIBASPHERE® (ribavirin, USP) Tablets for oral useInitial U.S. Appr

Ribavirin [richmond pharmaceuticals, inc.]

These highlights do not include all the information needed to use ribavirin capsules safely and effectively. See full prescribing information for ribavirin capsules.Ribavirin capsules 200 mgInitial U.S. Approval: 1998

Promacta [glaxosmithkline llc]

These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA.PROMACTA (eltrombopag) tablets, for oral usePROMACTA (eltrombopag) for oral suspensionInitial U.S. Approval: 2

Eylea [regeneron pharmaceuticals, inc.]

These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA (aflibercept) Injection, for Intravitreal InjectionInitial U.S. Approval: 2011

Ribavirin [american health packaging]

These highlights do not include all the information needed to use RIBAVIRIN CAPSULES safely and effectively. See full prescribing information for RIBAVIRIN CAPSULES. RIBAVIRIN capsules, for oral use Initial U.S. Approval: 1998

Plegridy [biogen inc.]

These highlights do not include all the information needed to use PLEGRIDY™ safely and effectively. See full prescribing information for PLEGRIDY.PLEGRIDY (peginterferon beta-1a) injection, for subcutaneous injectionInitial U.S. Approval: 2014

Ibrance [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE (palbociclib) capsules, for oral use Initial U.S. Approval: 2015

Aimovig [amgen inc]

These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018

Ibrance [u.s. pharmaceuticals]

These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE (palbociclib) capsules, for oral useInitial U.S. Approval: 2015

Sovaldi [gilead sciences, inc.]

These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. SOVALDI(sofosbuvir) tablets, for oral use Initial U.S. Approval: 2013



Advertisement
Quick Search
Advertisement
Advertisement